Search Results - M N Starovoytova

Features of systemic sclerosis-rheumatoid arthritis overlap syndrome (SS-RA overlap syndrome) by O. V. Desinova, M. N. Starovoytova, I. A. Guseva, A. A. Novikov, E. N. Alexandrova, N. G. Guseva

Get full text

Traditional cardiovascular risk factors and atherosclerosis in patients with systemic sclerosis by S. S. Shabanova, L. P. Ananjeva, T. V. Popkova, E. S. Mach, D. S. Novikova, M. N. Starovoytova, L. N. Kashnikova, E. L. Nasonov

Get full text

Characteristics of the new coronavirus infection (COVID-19) in patients with systemic sclerosis by M. N. Starovoytova, O. V. Desinova, L. P. Ananieva, O. A. Koneva, L. А. Garzanova, O. B. Ovsyannikova, R. U. Shayakhmetova

Get full text

Safety and tolerability of rituximab in the treatment of systemic sclerosis by L. A. Garzanova, L. P. Ananyeva, O. A. Koneva, O. V. Desinova, M. N. Starovoytova, O. B. Ovsyannikova, R. U. Shayakhmetova, S. I. Glukhova

Get full text

Short-term absolute B-cell counts monitoring in systemic sclerosis patients treated with rituximab by L. P. Ananieva, L. A. Garzanova, O. V. Desinova, O. A. Koneva, M. N. Starovoytova, O. B. Ovsyannikova, A. P. Aleksankn, S. I. Glukhova

Get full text

The use of the Scleroderma Clinical Trials Consortium Damage Index in systemic sclerosis by L. P. Ananyeva, V. V. Babak, A. D. Koltakova, O. A. Koneva, O. V. Desinova, M. N. Starovoytova, O. B. Ovsyannikova, R. U. Shayakhmetova

Get full text

The use of “Acellbia” – a biosimilar of rituximab in systemic sclerosis by L. P. Ananyeva, L. A. Garzanova, O. V. Desinova, R. U. Shayakhmetova, M. N. Starovoytova, O. A. Koneva, O. B. Ovsyannikova, S. I. Glukhova, E. L. Nasonov

Get full text

Anti-topoisomerase 1 antibody level changes after B сell depletion therapy in systemic sclerosis by L. P. Ananyeva, L. A. Garzanova, O. A. Koneva, M. N. Starovoytova, O. V. Desinova, O. B. Ovsyannikova, R. U. Shayakhmetova, M. V. Cherkasova, A. P. Aleksankin, E. L. Nasonov

Get full text

CLINICAL EVALUATION OF THE MANIFESTATIONS OF INTERSTITIAL LUNG INJURYIN SYSTEMIC SCLERODERMA FROM HIGH-RESOLUTION COMPUTER T OMOGRAPHY DATA by L P Anan'eva, L V Teplova, V N Lesnyak, O A Koneva, O B Ovsyannikova, M N Starovoytova, O V Desinova, L P Ananyeva, L V Teplova, V N Lesnyak, O A Koneva, O B Ovsyannikova, M N Starovoitova, O V Desinova

Get full text

Efficacy of divozilimab in the treatment of systemic sclerosis: results of the randomized phase III clinical trial BCD-132-5/LIBERIUS by L. P. Ananyeva, M. N. Starovoytova, I. Z. Gaydukova, G. V. Lukina, E. V. Zonova, L. V. Eliseeva, G. F. Fatkhullina, D. I. Abdulganieva, D. G. Krechikova, T. V. Kropotina, O. B. Nesmeyanova, I. B. Vinogradova, E. S. Zhugrova, L. V. Ivanova, N. E. Nikulenkova, O. R. Ziganshin, T. V. Plaksina, M. V. Zlobin, Yu. Yu. Grabovetskaya, N. F. Soroka, O. B. Ershova, T. V. Povarova, O. N. Anoshenkova, A. A. Lutsky, A. V. Zinkina-Orikhan, Yu. N. Linkova, E. A. Fokina, A. A. Porozova, A. V. Eremeeva

Get full text

The efficacy and safety of divozilimab in patient with systemic sclerosis: 48-week results of the randomized double-blind placebo-controlled phase III clinical study LIBERIUS by L. P. Ananyeva, M. N. Starovoytova, I. Z. Gaydukova, G. V. Lukina, E. V. Zonova, L. V. Eliseeva, G. F. Fatkhullina, D. I. Abdulganieva, D. G. Krechikova, T. V. Kropotina, O. B. Nesmeyanova, I. B. Vinogradova, E. S. Zhugrova, L. V. Ivanova, N. E. Nikulenkova, O. R. Ziganshin, T. V. Plaksina, M. V. Zlobin, Yu. Yu. Grabovetskaya, N. F. Soroka, O. B. Ershova, T. V. Povarova, O. N. Anoshenkova, A. A. Lutckii, A. V. Zinkina-Orikhan, Yu. N. Linkova, E. A. Fokina, A. A. Porozova, P. S. Pukhtinskaia, A. V. Eremeeva

Get full text